First FDA Approval for Newly Diagnosed Types of Peripheral T-Cell Lymphoma
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The Blood-Cancer.com team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
- FDA approves first-line treatment for peripheral T-cell lymphoma under new review pilot. US Food & Drug Administration. Available at https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm626079.htm?utm_campaign=111618_PR_FDA%20approves%20first-line%20treatment%20for%20peripheral%20T-cell%20lymphoma%20under%20new%20review%20pilot&utm_medium=email&utm_source=Eloqua. Accessed 11/19/18.
- FDA Gives Speedy Approval to Brentuximab for Peripheral T-cell Lymphoma. AJMC. Available at https://www.ajmc.com/newsroom/fda-gives-speedy-approval-to-brentuximab-for-peripheral-tcell-lymphoma. Accessed 11/19/18.
- Approval in 2 Weeks via FDA's New Oncology Drugs Review. Medscape. Available at https://www.medscape.com/viewarticle/905025. Accessed 11/19/18.
- Peripheral T-Cell Lymphoma Facts. Leukemia & Lymphoma Society. Available at https://www.lls.org/sites/default/files/file_assets/peripheraltcelllymphomafacts.pdf. Accessed 11/19/18.